Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Lomas

Showing results (211-220 of 282) with videos related to

Pageof 29
Sort By:
Pulmonary Therapy|November 17, 2020
Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT TrialDavid M G Halpin, Gerard J Criner, Mark T Dransfield, et al.
Chest|October 8, 2020
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment TrialNicola A Hanania, David M Mannino, Gerard J Criner, et al.
American Journal of Respiratory and Critical Care Medicine|February 21, 2014
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study teamJørgen Vestbo, Alvar Agusti, Emiel F M Wouters, et al.
Plos One|May 25, 2012
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypeAlvar Agustí, Lisa D Edwards, Stephen I Rennard, et al.
The New England Journal of Medicine|October 14, 2011
Changes in forced expiratory volume in 1 second over time in COPDJørgen Vestbo, Lisa D Edwards, Paul D Scanlon, et al.
Structure (London, England : 1993)|March 13, 2012
Structural dynamics associated with intermediate formation in an archetypal conformational diseaseMun Peak Nyon, Lakshmi Segu, Lisa D Cabrita, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 17, 2015
Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPDDavid M Mannino, Ruth Tal-Singer, David A Lomas, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2011
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary diseaseDon D Sin, Bruce E Miller, Annelyse Duvoix, et al.
Plos One|September 28, 2011
Genetics of sputum gene expression in chronic obstructive pulmonary diseaseWeiliang Qiu, Michael H Cho, John H Riley, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 4, 2017
Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1Merry-Lynn Noelle McDonald, Sungho Won, Manuel Mattheisen, et al.
Pageof 29

Showing results (211-220 of 282) with videos related to

Sort By:
Pageof 29
Pulmonary Therapy|November 17, 2020
Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT TrialDavid M G Halpin, Gerard J Criner, Mark T Dransfield, et al.
Chest|October 8, 2020
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment TrialNicola A Hanania, David M Mannino, Gerard J Criner, et al.
American Journal of Respiratory and Critical Care Medicine|February 21, 2014
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study teamJørgen Vestbo, Alvar Agusti, Emiel F M Wouters, et al.
Plos One|May 25, 2012
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypeAlvar Agustí, Lisa D Edwards, Stephen I Rennard, et al.
The New England Journal of Medicine|October 14, 2011
Changes in forced expiratory volume in 1 second over time in COPDJørgen Vestbo, Lisa D Edwards, Paul D Scanlon, et al.
Structure (London, England : 1993)|March 13, 2012
Structural dynamics associated with intermediate formation in an archetypal conformational diseaseMun Peak Nyon, Lakshmi Segu, Lisa D Cabrita, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 17, 2015
Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPDDavid M Mannino, Ruth Tal-Singer, David A Lomas, et al.
American Journal of Respiratory and Critical Care Medicine|January 11, 2011
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary diseaseDon D Sin, Bruce E Miller, Annelyse Duvoix, et al.
Plos One|September 28, 2011
Genetics of sputum gene expression in chronic obstructive pulmonary diseaseWeiliang Qiu, Michael H Cho, John H Riley, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 4, 2017
Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1Merry-Lynn Noelle McDonald, Sungho Won, Manuel Mattheisen, et al.
Pageof 29